Zinc-alpha-2-glycoprotein (ZAG), UniProt # P25311, is a soluble protein that was first isolated from human plasma. It is over-expressed in a number of malignant tumors and elevated serum levels are seen in prostate and cervical cancer. ZAG has also been shown to play a role in lipid mobilization and utilization.
| Description | |
| Immunogen | HEK293-derived recombinant ZAG. Gln21-Ser298. |
| Reactivity | Human |
| Source | Mouse monoclonal IgG1 |
| Purification | Protein G purified from hybridoma cell culture supernatant |
| Applications | ELISA, WB, IP |
| Formulation | Lyophilized from PBS with Trelahose Reconstitute in 100μL ddH20 to 1 mg/mL |
| Shipping | Ambient |
| Storage | 5 years at -20°C to -80°C as supplied 1 month at 4°C after reconstitution with preservative 1 year at -20°C to -80°C after reconstitution |
| Expiration | See lot specific CoA |
 | Human ZAG Luminex Assay Capture: Human ZAG monoclonal clone ZAG-5H4 (Cat # M2013) Detection: Human ZAG monoclonal clone ZAG-1B2 (Cat # M2014) Antigen: Recombinant human ZAG (Cat # P4001) |
| Immunoprecipitation of native ZAG SDS PAGE 4-12%, reducing conditions Blocking: 5% NFDM, PBS Sample: Human ZAG purified from human plasma with M2013 Blot was probed with 4μg/mL M2013 followed by HRP detection antibody. Human ZAG was detected at 44kDa. |
